Welcome to INNODIA MatchPoint
A centralized platform to report aggregated information on individuals identified in early stages of Type 1 Diabetes.
MatchPoint is designed for clinical sites that are implementing the INNODIA DETECT protocol without participating in MONITOR, as well as sites conducting independent screening activities outside of INNODIA.
By reporting simple aggregated numbers of identified individuals, sites contribute to expanding access to clinical trials and new therapeutic opportunities.
For clinical Sites
Access your portal using the secure link provided by your administrator.
On a quarterly basis, submit your site's aggregated information and track your submission history directly from your dashboard.
Site Submission
Report simple aggregated numbers of individuals identified with positive T1D autoantibodies, broken down by pediatric or adult age.
Your contribution in the tool will help expand access to clinical trials and therapeutic opportunities.
Privacy & Security
MatchPoint is not a patient registry, and no personal or identifiable data is collected – only aggregated information.
Everything is securely transmitted and stored on encrypted AWS infrastructure.
Site Portal Access
Log in to view your site's information, submit aggregated IAb+ numbers and manage submissions.